Trademark: 97022308
Word
ELEMLAB
Status
Pending
Status Code
731
Status Date
Thursday, November 30, 2023
Serial Number
97022308
Mark Type
4000
Filing Date
Friday, September 10, 2021
Published for Opposition
Tuesday, October 18, 2022

Trademark Owner History
Element Biosciences, Inc. - Owner At Publication

Classifications
9 Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices and analyzers
5 Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use; none of the forgoing for use in the veterinary field
1 Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes
10 Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices and analyzers, none of the forgoing for use in the veterinary field
42 Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings

Trademark Events
Nov 30, 2023
Sou Extension 2 Granted
Nov 30, 2023
Sou Extension 2 Filed
Nov 30, 2023
Sou Teas Extension Received
Jun 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 6, 2023
Sou Extension 1 Granted
Jun 6, 2023
Sou Extension 1 Filed
Jun 6, 2023
Sou Teas Extension Received
Dec 13, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 18, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 18, 2022
Published For Opposition
Sep 28, 2022
Notification Of Notice Of Publication E-Mailed
Sep 9, 2022
Approved For Pub - Principal Register
Aug 31, 2022
Teas/Email Correspondence Entered
Aug 30, 2022
Correspondence Received In Law Office
Aug 30, 2022
Teas Response To Office Action Received
Mar 1, 2022
Notification Of Non-Final Action E-Mailed
Mar 1, 2022
Non-Final Action E-Mailed
Mar 1, 2022
Non-Final Action Written
Feb 28, 2022
Assigned To Examiner
Oct 19, 2021
New Application Office Supplied Data Entered
Sep 14, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24